BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
JA Silver, M Bogatchenko… - … -Head & Neck …, 2021 - journals.sagepub.com
Background While some studies suggest that the BRAF V600E mutation correlates with a
high-risk phenotype in papillary thyroid microcarcinoma (PTMC), more evidence is …
high-risk phenotype in papillary thyroid microcarcinoma (PTMC), more evidence is …
Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma
YS Kim, JS Kim, JS Bae, WC Park - World Journal of Surgical Oncology, 2013 - Springer
Abstract Background The BRAF V600E mutation is the most common genetic alteration in
papillary thyroid carcinoma (PTC). In recent studies, the BRAF V600E mutation has been …
papillary thyroid carcinoma (PTC). In recent studies, the BRAF V600E mutation has been …
The relationship between the BRAFV600E mutation in papillary thyroid microcarcinoma and clinicopathologic factors
SY Choi, HS Park, MK Kang, DK Lee, KD Lee… - World journal of surgical …, 2013 - Springer
Abstract Background The BRAF V600E mutation, which accounts for about 60–80%
papillary thyroid carcinoma (PTC), has been identifiedas a prognostic marker for risk …
papillary thyroid carcinoma (PTC), has been identifiedas a prognostic marker for risk …
BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma
HF Lai, JF Hang, PC Kuo, CS Kuo, SF Yao… - Annals of Surgical …, 2024 - Springer
Background Previous literatures showed wide range of prevalence of BRAF V600E in
papillary thyroid carcinoma (PTC). The correlation of BRAF V600E mutation with aggressive …
papillary thyroid carcinoma (PTC). The correlation of BRAF V600E mutation with aggressive …
BRAFV600E mutation in fine‐needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas
JI Lee, HW Jang, SW Kim, JW Kim, YL Oh… - Head & …, 2013 - Wiley Online Library
Background Recent studies have shown that BRAFV600E mutation is associated with poor
prognostic factors in papillary thyroid carcinoma (PTC). However, there are no studies about …
prognostic factors in papillary thyroid carcinoma (PTC). However, there are no studies about …
Incidence of BRAF V600E mutation in patients with papillary thyroid carcinoma: a single-institution experience
S Kure, K Ishino, M Kudo, R Wada… - Journal of …, 2019 - journals.sagepub.com
Objective Papillary thyroid carcinoma (PTC) accounts for 95% of all thyroid carcinomas. PTC
is an epithelial tumor characterized by the proliferation of follicular cells with distinctive …
is an epithelial tumor characterized by the proliferation of follicular cells with distinctive …
The association between BRAF V600E mutation and pathological features in PTC
X Liu, K Yan, X Lin, L Zhao, W An, C Wang… - European archives of oto …, 2014 - Springer
Abstract The BRAF V600E mutation is a common genetic alteration in papillary thyroid
carcinoma (PTC) and is associated with some pathological features. The association has …
carcinoma (PTC) and is associated with some pathological features. The association has …
BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
Abstract Background The BRAF V600E mutation is the most common genetic alteration
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
BRAFV600E Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer
S Fraser, C Go, A Aniss, S Sidhu, L Delbridge… - World journal of …, 2016 - Springer
Abstract Background The BRAF V600E mutation is a recognised molecular marker in
papillary thyroid cancer (PTC), reported incidence from 30 to 80%. BRAF V600E aberrantly …
papillary thyroid cancer (PTC), reported incidence from 30 to 80%. BRAF V600E aberrantly …
Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma
J Zagzag, A Pollack, L Dultz, S Dhar, JB Ogilvie… - Surgery, 2013 - Elsevier
Background BRAF V600E mutation is the most common genetic alteration in papillary
thyroid cancer (PTC). We used a mutation-specific antibody for immunohistochemical (IHC) …
thyroid cancer (PTC). We used a mutation-specific antibody for immunohistochemical (IHC) …
相关搜索
- braf v600e mutation in patients
- aggressive features thyroid carcinomas
- survival in papillary thyroid cancer
- brafv600e mutation thyroid carcinomas
- thyroid carcinoma oncogenic mutations
- thyroid carcinoma immunohistochemistry for the detection
- thyroid carcinoma clinical implication
- thyroid carcinoma clinical utility
- thyroid carcinoma poor prognosis
- clinicopathologic factors thyroid microcarcinoma
- patients with papillary thyroid carcinoma
- poor prognosis oncogenic mutations